The number of individuals filling prescriptions for all medications decreased “considerably” in the early days of the COVID-19 pandemic, researchers wrote in JAMA Internal Medicine.
However, the number of individuals who filled prescriptions for buprenorphine “plateaued” but did not “decrease” during this period, they added.
“Americans with opioid use disorder are a vulnerable population during the COVID-19 pandemic, with recent data suggesting a substantial increase in overdoses,” Thuy D. Nguyen, PhD, a research assistant professor of health
Uncategorized